Theophylline Tablet, Extended Release
Product Images NDC 62135-457

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 62135-457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Theophylline Extended Release Tablets 300 mg (NDC 62135-457-90)

Theophylline Extended Release Tablets 300 mg (NDC 62135-457-90)
Label for Theophylline Extended-Release Tablets, 300 mg strength, oral dosage form. The label shows a count of 90 tablets and is marked Rx Only. The manufacturer is Chartwell RX, LLC. The label includes storage instructions, cautions to keep out of reach of children, and a barcode.*
FDA Label Image

Image Description (Theophylline Er Tablets Structure)

Image Description (Theophylline Er Tablets Structure)
Chemical structure of the active ingredient Theophylline (C7H8N4O2) with molecular weight 180.17, as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.